Springdale, Arkansas — Springdale, Arkansas

Springdale, Arkansas is a clinical research site located in Springdale, Arkansas, United States 72764.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Springdale, Arkansas has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Diabetic Macular Edema (DME).

Sponsors: EyeBiotech Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Springdale

Browse all research sites in Arkansas · View every site in Springdale

• University of Arkansas for Medical Sciences Northwest
• Highlands Oncology Group
• Research Site
• Highlands Oncology Group, PA
• Highlands Oncology Group Springdale
• Alkermes Investigational Site
• Highlands Oncology
• Retina Partners of Northwest Arkansas, PLLC
• Northwest Arkansas Retina Associates
• UAMS Institute for Community Health Innovation
• Pfizer Investigational Site
• Woodland Research Northwest

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Springdale, Arkansas?

Springdale, Arkansas has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Springdale, Arkansas conducted?

Springdale, Arkansas has 1 clinical trials on record, with 1 currently active. Their work covers Diabetic Macular Edema (DME).

Is Springdale, Arkansas accredited by Crixeo Clinical Trials?

Springdale, Arkansas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Springdale, Arkansas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.